Ewing’s sarcoma of the male external genitalia: a case report and review of the literature

Due to the clinically silent nature of paratesticular tumors before a noticeable mass effect, it is challenging to diagnose them. Differentials for such masses include benign lesions such as lipomas, hemangiomas, lymphangiomas, leiomyomas [6] and adenomatoid tumors which account for 30% of all paratesticular masses [7]. Malignant differentials include liposarcoma, leiomyosarcoma, and rhabdomyosarcoma. Other rare paratesticular differentials include ovarian-type tumors arising from Mullerian metaplasia of the tunica vaginalis, desmoplastic small cell tumors, and melanotic neuroectodermal tumors [8]. Although ES has a propensity for extraosseous presentations, the reason for this affinity is relatively unknown. Further research is warranted to evaluate the pathophysiology of extraskeletal ES and to determine if genetic testing can play a role in the workup of paratesticular malignancies.

Scrotal sarcomas are rare and are commonly liposarcomas, rhabdomyosarcomas, or leiomyosarcomas [6]. It has been suggested that for these tumors, a CT or magnetic resonance imaging (MRI) scan is preferred to diagnose liposarcoma due to the presence of abnormal fat appearing with unreliable echogenicity on ultrasound [9]. It is also posited that MRI can provide a better characterization of tissue that may correlate with the histologic type of testicular tumor [10, 11]. Diagnostic precision may be greater with MRI, not only in testicular masses but also in spermatic cord masses [12]. However, for other tumors such as rhabdomyosarcoma, leiomyosarcoma, and ES, their imaging appearance is non-specific, often showing increased vascularity on ultrasound (US) or variable heterogenous enhancement on MRI [9]. Interestingly, the original US, in combination with relatively normal tumor markers, for our patient suggested a benign adenomatoid tumor, which could have initially deescalated surgical intervention. Use of imaging modalities to elucidate between benign and malignant tumors of the scrotum is both challenging and interesting due to unique embryologic origins of paratesticular region allowing for rare malignant pathologies [6]. Further research on imaging guidelines for paratesticular masses is warranted.

Presentations of ES in the male external genitalia are rare, and a review of the literature reveals one reported case of ES within the scrotum but in a 3-year-old-boy with a 2-year history of painless growing mass [5]. The patient had no evidence of metastatic disease at the time of presentation. After surgical resection, due to positive margins, the patient returned for another resection. He underwent chemotherapy with vincristine, doxorubicin, and cyclophosphamide.

On our review of the literature, other primary ES of the male external genitalia has been reported in the penis at least four times. One such case in the penis resulted in a total penile amputation in a young 32-year-old man who subsequently underwent 8 cycles of chemotherapy according to the EuroEwing 99 protocol [4]. The patient was then cancer-free for 3 years before a diagnosis of lung metastases was made, followed by additional chemotherapy and resection. Unfortunately, the patient died due to rapid tumor progression from several recurrences of ES over the next 4 years. Another case of penile ES reported by Toh et al. occurred in a 21-year-old male with a penile lesion, peritoneal mass, and lung metastasis at the time of diagnosis who was later treated with chemotherapy resulting in initial regression but tumor progression 8 months later [13]. Additionally, a 17-year-old with ES of the penis presented with metastasis in the lungs, ribs, lumbar vertebrae, and sacrum at the time of diagnosis [14]. Unfortunately, he died from lung metastasis complications and sepsis 2 months later. Another case was found at the base of the penis but was misdiagnosed as an endocrine disorder before a confirmed ES diagnosis was made at the time of massive lung metastasis [15].

Ewing’s Sarcoma is a cancer most commonly found in children, and much of its management in adults is modeled from pediatric protocols [16]. Due to the rarity of extraossesous ES, there is no consistent algorithm for treatment but it has been proposed that extraskeletal ES and even paratesticular neuroectodermal tumors should be treated with the same ES protocol used in bone tumors [4, 17]. The standard surgical approach to soft tissue sarcomas is a wide excision with negative margins (R0, no microscopic disease); similar principles should be followed. Kushner et al. demonstrated that high doses of cyclophosphamide, doxorubicin, vincristine, ifosfamide, and etoposide generates excellent results in young children and adults [18]. Likewise, a prospective study described the same treatment protocol for both Ewing’s sarcoma and peripheral neuroepithelioma in children and young adults showing no difference in disease-free survival rates for both groups of primitive neuroectodermal tumors [19].

Although not the focus of this discussion, it is worthwhile to note that several cases of primary Ewing’s sarcoma in both children and adults within the bladder, ureter and kidney have been reported and treated with a combination of surgical resection, chemotherapy and radiation [20,21,22,23].

In conclusion our case is not only the first known report of paratesticular Ewing Sarcoma in an adult, but it also represents a unique case of an initial apparent adenomatoid tumor on ultrasound that was later found to be primary ES. Although there are several reports of ES in the genitourinary system, there is ultimately one known report of ES in the scrotum and a handful of cases of penile ES. Rare diseases such as this case of a paratesticular Ewing sarcoma in an adult warrant consideration of unique differential diagnoses for scrotal masses. This disease appears to be treated best with surgical resection and adjuvant chemotherapy; however, despite treatment, prognosis is often dismal once metastatic disease develops. Diagnosis and treatment of cases in the adult population is often challenging. Current treatment post-surgical resection in pediatric and adult cases involves adjuvant chemotherapy and possible radiation, according to ES protocols per the National Comprehensive Cancer Network. Future investigation of appropriate diagnostic and management algorithms for extraosseous ES may be considered.

留言 (0)

沒有登入
gif